InvestorsObserver
Sign Up Login

EPIX Essa Pharma

$1.77 $0.00 (0.00%)
Add to Watchlist Compare
Overall

EPIX Stock Analysis Overview

What this means: InvestorsObserver gives Essa Pharma (EPIX) an overall rank of 46, which is below average. Essa Pharma is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 46 means that 54% of stocks appear more favorable to our system.

Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.

View Sample Report
Fundamental PREMIUM

EPIX Fundamental Analysis

Who this matters to: The Fundamental Ranking considers the health of the underlying company. It is best used by longer-term buy-and-hold investors.

Upgrade to Premium to unlock Fundamental Ranking

Short-Term Technical PREMIUM

EPIX Short-Term Technical Analysis

Who this matters to: The Short-Term Technical Ranking evaluates a stock’s trading over the past month. This is most useful for short- to medium-term stock and option traders.

Upgrade to Premium to unlock Short-Term Technical Ranking

Long-Term Technical PREMIUM

EPIX Long-Term Technical Analysis

Who this matters to: The Long-Term Technical Ranking is a good gauge of how a stock has traded over the past several months. This is useful for medium to long-term stock and option traders.

Upgrade to Premium to unlock Long-Term Technical Ranking

Analyst Ranking PREMIUM

EPIX Analyst Ranking

Who this matters to: Analyst Ranking shows you which stocks Wall Street analysts like the most. Since analysts build valuation models, this is most useful for medium to long-term investors who are interested in a valuation-based approach.

Upgrade to Premium to unlock Analyst Ranking Analysis

Valuation PREMIUM

EPIX Valuation Ranking Analysis

Who this matters to: Valuation Ranking is most-useful for value-focused investors who plan to hold a stock for the long term.

Upgrade to Premium to unlock Valuation Ranking

Stock Sentiment PREMIUM

EPIX Stock Sentiment Analysis

Who this matters to: Sentiment Rank looks at the past five trading days. This is our shortest-term evaluation and is best used by people with a very short horizon.

Upgrade to Premium to unlock Stock Sentiment Ranking

EPIX Stock Analysis Overview

What this means: InvestorsObserver gives Essa Pharma (EPIX) an overall rank of 46, which is below average. Essa Pharma is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 46 means that 54% of stocks appear more favorable to our system.

Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.

Create a FREE account to see full EPIX report

EPIX Fundamental Analysis

Who this matters to: The Fundamental Ranking considers the health of the underlying company. It is best used by longer-term buy-and-hold investors.

Upgrade to Premium to unlock Fundamental Ranking

EPIX Short-Term Technical Analysis

Who this matters to: The Short-Term Technical Ranking evaluates a stock’s trading over the past month. This is most useful for short- to medium-term stock and option traders.

Upgrade to Premium to unlock Short-Term Technical Ranking

EPIX Long-Term Technical Analysis

Who this matters to: The Long-Term Technical Ranking is a good gauge of how a stock has traded over the past several months. This is useful for medium to long-term stock and option traders.

Upgrade to Premium to unlock Long-Term Technical Ranking

EPIX Analyst Ranking

Who this matters to: Analyst Ranking shows you which stocks Wall Street analysts like the most. Since analysts build valuation models, this is most useful for medium to long-term investors who are interested in a valuation-based approach.

Upgrade to Premium to unlock Analyst Ranking Analysis

EPIX Valuation Ranking Analysis

Who this matters to: Valuation Ranking is most-useful for value-focused investors who plan to hold a stock for the long term.

Upgrade to Premium to unlock Valuation Ranking

EPIX Stock Sentiment Analysis

Who this matters to: Sentiment Rank looks at the past five trading days. This is our shortest-term evaluation and is best used by people with a very short horizon.

Upgrade to Premium to unlock Stock Sentiment Ranking

Essa Pharma (EPIX) Analyst Forecast

EPIX Price, Volume, Earnings, and Dividend Date

  • Last Price $1.77
  • Previous Close $1.77
  • Change $0.00
  • Open $1.82
  • Volume 56,900
  • Avg. Volume (100-day) 314,123
  • Market Cap 51,345,064
  • Days Range 1.72 - 1.84
  • 52-week Range 1.66 - 14.88
  • Dividend Yield —
  • Ex. Dividend Date —
  • P-E —
  • EPS —
  • Earnings Date 11/17/22
  • Sector Healthcare
  • Industry Biotechnology
  • Avg. Analyst Rec. Premium
  • Beta 0.926
  • PEG Ratio —

Essa Pharma (EPIX) Company Description

ESSA Pharma Inc is a pharmaceutical company. The company is in the preclinical stage, focused on the development of small molecule drugs for the treatment of castration-resistant prostate cancer. The company is developing drugs that selectively block the amino-terminal domain of the androgen receptor, potentially overcoming the known AR-dependent resistance mechanisms of CRPC and providing CRPC patients with the potential for increased progression-free and overall survival.

Essa Pharma (EPIX) Stock Chart

View Interactive EPIX chart

My Watchlists

Follow Your Favorite Stocks

Top Stocks in Biotechnology

Company Price
G1 Therapeutics Inc (GTHX) (GTHX) $12.41
Ardelyx Inc (ARDX) (ARDX) $1.34
Satsuma Pharmaceuticals Inc (STSA) (STSA) $5.30
Pliant Therapeutics Inc (PLRX) (PLRX) $21.02
Liquidia Corp (LQDA) (LQDA) $5.52
Axsome Thera (AXSM) (AXSM) $45.33
Fireman B.V. (IFRX) (IFRX) $2.71
Wave Life Sci Ord Sh (WVE) (WVE) $3.54
Concert Pharmaceutic (CNCE) (CNCE) $6.60
Capricor Therap (CAPR) (CAPR) $6.10